Q1FY27 Results: PAT dips, revenue up 37%; 3600 ESOPs granted

Revenue Growth 20pctResults View source PDF Explain this filing

ARMANFIN · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.5%Reaction day

₹2009.00

prior close

₹2073.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.2%+0.4% vs market

Non Banking Financial Company (NBFC) peers, median of 209sector+0.2%+0.3% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.3 pts more than its Non Banking Financial Company (NBFC) peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-1.2

10m

+2.7

15m

+2.3

30m

+2.6

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.5+0.2+0.4+0.2+0.3

Next day

-2.2+0.2-2.4-0.1-2.1

-2.6+0.4-3.0-0.6-2.0

-3.3+0.7-4.0-0.9-2.4

-3.6+0.1-3.8-1.3-2.4

-1.4+0.7-2.1-0.8-0.7

-3.4+1.2-4.5-0.9-2.4

15d

-0.4+0.7-1.2-0.9+0.5

-4.1-1.2-2.9-2.2-1.9

-16.7-1.1-15.5-4.4-12.3

—————

UpDownMarket · Nifty Microcap 250Sector · Non Banking Financial Company (NBFC) peers, median of 209Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Board approved Q1FY27 (quarter ended June 30, 2026) results. Consolidated total income rose 37% YoY to Rs. 20,541.87 lakh from Rs. 15,026.09 lakh, but net profit fell 9% to Rs. 4,101.33 lakh from Rs. 4,517.15 lakh. Standalone net profit slipped to Rs. 1,244.99 lakh from Rs. 1,459.09 lakh. EPS stood at Rs. 11.87 (standalone). Debt-equity ratio at 2.01x, Stage III assets at 2.76%. Also granted 3600 ESOPs at Rs. 500 each and appointed Mr. Pushpendrakumar as Head Internal Audit.

Likely market impact

Strong top-line growth but bottom-line contraction and rising finance costs may pressure the stock; minor ESOP dilution.